• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchArvinas
    Picture of Arvinas logo

    ARVN — Arvinas News Story

    $7.720.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    • Market Cap
      $504.78m
    • Enterprise Value
      -$62.82m
    • Revenue
      $262.60m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ARVN Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ARVN Dividends
    All News

    NASDAQ TRADE HALT HALT NEWS PENDING AT 11:22 AM

    Picture of Arvinas logoArvinas
    01/05/2026 16:22
    NASDAQ TRADE HALT  ARVN.O  HALT NEWS PENDING AT 11:22 AM
    

    Recent news on Arvinas

    See all news
    • Brief: Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

      01/09/2026 21:09
    • Arvinas Inc reports results for the quarter ended June 30 - Earnings Summary

      04/08/2026 14:31
    • Brief: Arvinas - Pfizer, And Rigel Receive Hart-Scott-Rodino Clearance For License Agreement On June 11, 2026

      16/06/2026 21:33
    • Brief: Arvinas - Announces Re-Prioritization Of Portfolio Following Strategic Review - SEC Filing

      02/06/2026 21:58
    • U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology

      14/05/2026 08:24

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.